Cargando…
Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives
The novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). Mesenchymal stem cells (MSCs) are currently utilized in clinics for pulmonary inflammatory diseases, including acute respiratory distress syndrome and acute lung injury. Give...
Autores principales: | Karakaş, Nihal, Üçüncüoğlu, Süleyman, Uludağ, Damla, Karaoğlan, Birnur Sinem, Shah, Khalid, Öztürk, Gürkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834073/ https://www.ncbi.nlm.nih.gov/pubmed/35159275 http://dx.doi.org/10.3390/cells11030465 |
Ejemplares similares
-
Neurons from human mesenchymal stem cells display both spontaneous and stimuli responsive activity
por: Karakaş, Nihal, et al.
Publicado: (2020) -
A bioengineering perspective on modelling the intestinal epithelial physiology in vitro
por: Antfolk, Maria, et al.
Publicado: (2020) -
Mesenchymal stem cell therapy for severe COVID-19
por: Shi, Lei, et al.
Publicado: (2021) -
Bioengineering an Artificial Human Blood–Brain Barrier in Rodents
por: Kamal, Kimia, et al.
Publicado: (2019) -
The Influence of a Blind Professor in a Bioengineering Course
por: Greenvall, Benjamin R., et al.
Publicado: (2021)